Polatuzumab Vedotin From Beginning to Approval & Beyond

Time: 9:00 am
day: Day One

Details:

• Reviewing the discovery of Polatuzumab
• Evaluating early clinical data and gaining approval
• Exploring future combinations

Speakers: